Just my take.... though I have my own set of jitters about this, I would not assume that Hepalink trading down right now is necessarily ominous for Phase 3 results.

Hepalink is a huge company, and though it has made a sizeable investment in RVX, that investment is not large enough to break Hepalink regardless of outcome.  

It seems more likely to me that any down trading has to do with market trends in China, possibly in small part to market concerns about cooling relations w US market and Trump statements about reducing medical reliance on China, but even then there are other growing markets. I suspect right now we need them more than they need us, medicine wise.

I also could have sworn i read something a while back about changes in management, but could NOT find those articles agsin so that may be way off base. But IF that memory was not off the wall, that could also be a factor. Really not sure, just suspect it has nothing to do with Top Line Results.

Markets seem a bit shaky all over. May be tough timing for us, but still thrilled and excited.

Frankly, even if we fail to meet top line goals, it seems likely to me that this compound has uses. Whether RVX survives to market to those will be an interesting question  But hoping for the win.

GLTA